000 01069 a2200277 4500
005 20250518092514.0
264 0 _c20201204
008 202012s 0 0 eng d
022 _a1526-4637
024 7 _a10.1093/pm/pnaa057
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWee, Tze Chao
245 0 0 _aHigh-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments.
_h[electronic resource]
260 _bPain medicine (Malden, Mass.)
_c10 2020
300 _a2603-2604 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aDiabetes Mellitus
650 0 4 _aDiabetic Neuropathies
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
650 0 4 _aPain
700 1 _aTan, Yeow Leng
773 0 _tPain medicine (Malden, Mass.)
_gvol. 21
_gno. 10
_gp. 2603-2604
856 4 0 _uhttps://doi.org/10.1093/pm/pnaa057
_zAvailable from publisher's website
999 _c30764668
_d30764668